Helsinn Announces EUR6 Million Investment in Helsinn Birex Pharmaceuticals to Safeguard the Quality and Authenticity of Its Products

Lugano, Switzerland, May 24 (Korea Bizwire) – Helsinn, a Swiss pharmaceutical group focused on building quality cancer care products, today announced a €6million investment at its drug product supply centre, Helsinn Birex Pharmaceuticals Ltd (HBP) in Dublin Ireland, as part of its ongoing commitment to ensuring high quality products, safeguarding its supply chain and in compliance [...]